Ascenion Mediates Licence Agreement between medac and MHH for New Diagnostic Test in Acute Lymphoblastic Leukaemia (ALL)
30-Mar-2009 -
Hanover Medical School (MHH) and medac GmbH have closed a licence agreement providing the company with exclusive worldwide rights to a diagnostic test that can help guide Acute Lymphoblastic Leukaemia (ALL) treatment. The deal was initiated and negotiated by Ascenion GmbH, the MHH's exclusive ...
Ascenion
bone marrow
central nervous system
+4